Abstract
In May 2011 the National Lipid Association (NLA) issued new recommendations for the treatment of familial hypercholesterolemia (FH). This Journal of Clinical Lipidology open-source eCME activity (accessed at http:// multimedia.lipidjournal.com/2011/HDL) reviews public awareness, medical diagnosis, and current evidence-based treatment for FH. FH is caused by genetic mutations that affect the function of low-density lipoprotein (LDL)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
